Cargando…

Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma

BACKGROUND: Vascular endothelial growth factor D (VEGFD), a member of the VEGF family, is implicated in angiogenesis and lymphangiogenesis, and is deemed to be expressed at a low level in cancers. S-nitrosylation, a NO (nitric oxide)-mediated post-translational modification has a critical role in an...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qiangqiang, Qu, Meiyu, Shen, Tingyu, Xu, Yana, Luo, Jiahao, Tan, Dan, Xu, Chengyun, Barkat, Muhammad Qasim, Zeng, Ling-Hui, Wu, Ximei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358865/
https://www.ncbi.nlm.nih.gov/pubmed/35941690
http://dx.doi.org/10.1186/s13046-022-02453-8
_version_ 1784764020054556672
author He, Qiangqiang
Qu, Meiyu
Shen, Tingyu
Xu, Yana
Luo, Jiahao
Tan, Dan
Xu, Chengyun
Barkat, Muhammad Qasim
Zeng, Ling-Hui
Wu, Ximei
author_facet He, Qiangqiang
Qu, Meiyu
Shen, Tingyu
Xu, Yana
Luo, Jiahao
Tan, Dan
Xu, Chengyun
Barkat, Muhammad Qasim
Zeng, Ling-Hui
Wu, Ximei
author_sort He, Qiangqiang
collection PubMed
description BACKGROUND: Vascular endothelial growth factor D (VEGFD), a member of the VEGF family, is implicated in angiogenesis and lymphangiogenesis, and is deemed to be expressed at a low level in cancers. S-nitrosylation, a NO (nitric oxide)-mediated post-translational modification has a critical role in angiogenesis. Here, we attempt to dissect the role and underlying mechanism of S-nitrosylation-mediated VEGFD suppression in lung adenocarcinoma (LUAD). METHODS: Messenger RNA and protein expression of VEGFD in LUAD were analyzed by TCGA and CPTAC database, respectively, and Assistant for Clinical Bioinformatics was performed for complex analysis. Mouse models with urethane (Ure)–induced LUAD or LUAD xenograft were established to investigate the role of S-nitrosylation in VEGFD expression and of VEGFD mutants in the oncogenesis of LUAD. Molecular, cellular, and biochemical approaches were applied to explore the underlying mechanism of S-nitrosylation-mediated VEGFD suppression. Tube formation and wound healing assays were used to examine the role of VEGFD on the angiogenesis and migration of LUAD cells, and the molecular modeling was applied to predict the protein stability of VEGFD mutant. RESULTS: VEGFD mRNA and protein levels were decreased to a different extent in multiple primary malignancies, especially in LUAD. Low VEGFD protein expression was closely related to the oncogenesis of LUAD and resultant from excessive NO-induced VEGFD S-nitrosylation at Cys277. Moreover, inhibition of S-nitrosoglutathione reductase consistently decreased the VEGFD denitrosylation at Cys277 and consequently promoted angiogenesis of LUAD. Finally, the VEGFD(C277S) mutant decreased the secretion of mature VEGFD by attenuating the PC7-dependent proteolysis and VEGFD(C277S) mutant thus reversed the effect of VEGFD on angiogenesis of LUAD. CONCLUSION: Low-expression of VEGFD positively correlates with LUAD development. Aberrant S-nitrosylation of VEGFD negates itself to induce the tumorigenesis of LUAD, whereas normal S-nitrosylation of VEGFD is indispensable for its secretion and repression of angiogenesis of LUAD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-022-02453-8.
format Online
Article
Text
id pubmed-9358865
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93588652022-08-10 Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma He, Qiangqiang Qu, Meiyu Shen, Tingyu Xu, Yana Luo, Jiahao Tan, Dan Xu, Chengyun Barkat, Muhammad Qasim Zeng, Ling-Hui Wu, Ximei J Exp Clin Cancer Res Research BACKGROUND: Vascular endothelial growth factor D (VEGFD), a member of the VEGF family, is implicated in angiogenesis and lymphangiogenesis, and is deemed to be expressed at a low level in cancers. S-nitrosylation, a NO (nitric oxide)-mediated post-translational modification has a critical role in angiogenesis. Here, we attempt to dissect the role and underlying mechanism of S-nitrosylation-mediated VEGFD suppression in lung adenocarcinoma (LUAD). METHODS: Messenger RNA and protein expression of VEGFD in LUAD were analyzed by TCGA and CPTAC database, respectively, and Assistant for Clinical Bioinformatics was performed for complex analysis. Mouse models with urethane (Ure)–induced LUAD or LUAD xenograft were established to investigate the role of S-nitrosylation in VEGFD expression and of VEGFD mutants in the oncogenesis of LUAD. Molecular, cellular, and biochemical approaches were applied to explore the underlying mechanism of S-nitrosylation-mediated VEGFD suppression. Tube formation and wound healing assays were used to examine the role of VEGFD on the angiogenesis and migration of LUAD cells, and the molecular modeling was applied to predict the protein stability of VEGFD mutant. RESULTS: VEGFD mRNA and protein levels were decreased to a different extent in multiple primary malignancies, especially in LUAD. Low VEGFD protein expression was closely related to the oncogenesis of LUAD and resultant from excessive NO-induced VEGFD S-nitrosylation at Cys277. Moreover, inhibition of S-nitrosoglutathione reductase consistently decreased the VEGFD denitrosylation at Cys277 and consequently promoted angiogenesis of LUAD. Finally, the VEGFD(C277S) mutant decreased the secretion of mature VEGFD by attenuating the PC7-dependent proteolysis and VEGFD(C277S) mutant thus reversed the effect of VEGFD on angiogenesis of LUAD. CONCLUSION: Low-expression of VEGFD positively correlates with LUAD development. Aberrant S-nitrosylation of VEGFD negates itself to induce the tumorigenesis of LUAD, whereas normal S-nitrosylation of VEGFD is indispensable for its secretion and repression of angiogenesis of LUAD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-022-02453-8. BioMed Central 2022-08-08 /pmc/articles/PMC9358865/ /pubmed/35941690 http://dx.doi.org/10.1186/s13046-022-02453-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
He, Qiangqiang
Qu, Meiyu
Shen, Tingyu
Xu, Yana
Luo, Jiahao
Tan, Dan
Xu, Chengyun
Barkat, Muhammad Qasim
Zeng, Ling-Hui
Wu, Ximei
Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma
title Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma
title_full Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma
title_fullStr Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma
title_full_unstemmed Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma
title_short Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma
title_sort suppression of vegfd expression by s-nitrosylation promotes the development of lung adenocarcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358865/
https://www.ncbi.nlm.nih.gov/pubmed/35941690
http://dx.doi.org/10.1186/s13046-022-02453-8
work_keys_str_mv AT heqiangqiang suppressionofvegfdexpressionbysnitrosylationpromotesthedevelopmentoflungadenocarcinoma
AT qumeiyu suppressionofvegfdexpressionbysnitrosylationpromotesthedevelopmentoflungadenocarcinoma
AT shentingyu suppressionofvegfdexpressionbysnitrosylationpromotesthedevelopmentoflungadenocarcinoma
AT xuyana suppressionofvegfdexpressionbysnitrosylationpromotesthedevelopmentoflungadenocarcinoma
AT luojiahao suppressionofvegfdexpressionbysnitrosylationpromotesthedevelopmentoflungadenocarcinoma
AT tandan suppressionofvegfdexpressionbysnitrosylationpromotesthedevelopmentoflungadenocarcinoma
AT xuchengyun suppressionofvegfdexpressionbysnitrosylationpromotesthedevelopmentoflungadenocarcinoma
AT barkatmuhammadqasim suppressionofvegfdexpressionbysnitrosylationpromotesthedevelopmentoflungadenocarcinoma
AT zenglinghui suppressionofvegfdexpressionbysnitrosylationpromotesthedevelopmentoflungadenocarcinoma
AT wuximei suppressionofvegfdexpressionbysnitrosylationpromotesthedevelopmentoflungadenocarcinoma